tion, which is initiated by the MBL/MASPs complex, evidently contributes to the development of glomerular
the first line of host defense against these pathogens.
Immunohistochemical studies were performed using the Therefore, discerning the role and the mechanism of avidin-biotin peroxidase method as previously described [17] .
the lectin pathway in IgA-N will provide insights into Briefly, frozen biopsy tissues cut serially into 3 mm sections the pathogenesis of this disorder.
were fixed in cold acetone, air dried, and were washed in In this study, we first demonstrated glomerular depos-phosphate-buffered saline (PBS). The fixed sections were ition of MBL/MASP-1 to prove that the lectin pathway immersed in methanol containing 0.3% hydrogen peroxide played a significant role in the pathogenesis of IgA-N. (v/v) to quench the endogenous peroxidase activity. NonFurthermore, the clinicopathological features of the specific protein binding sites were blocked with 10% normal rabbit serum in PBS. The sections were consecutively incubated cases with MBL/MASP-1 deposition were examined.
with mAbs overnight at 4°C, washed in PBS, and incubated with biotin-conjugated F(ab')2 fragments of rabbit antibody to mouse IgG (DAKO) for 30 min at room temperature. After
Subjects and methods
washing in PBS, the sections were incubated with the avidin-biotin-peroxidase complex (ABC Vectastatin Elite kit; Vector,
Patients, clinical and histological data
Burlingame, CA), re-washed in PBS, and treated with diaminobenzidine. Finally, the sections were counter-stained with Forty-five patients with primary IgA-N, who had been haematoxylin, mounted, and observed using a conventional referred to the Itabashi Hospital of Nihon University, were light microscope. In addition, normal portions of kidneys studied. Diagnosis was made by standard examination of the obtained as a result of nephrectomies performed in four renal biopsy specimen by light microscopy and immunofluo-patients due to renal tumours and renal biopsy specimens from rescence (IF ). None of the cases had clinical or serological 35 patients with various types of glomerulonephritis (GN ), evidence of systemic lupus erythematosus, Schö nlein-Henoch including 10 with mesangial proliferative GN (non-IgA), four purpura, or liver disease including liver cirrhosis. The age of with membranous nephropathy, three with focal glomerulothe patients at the time of biopsy ranged from 15 to 48 years sclerosis, two with mesangiocapillary GN, nine with minimal and the group included 21 males and 24 females (male/ change nephrotic syndrome, one with thin-basement memfemale ratio of 0.875). The relevant clinical parameters brane disease, and six with lupus nephritis, were examined to ascertained at the time of presentation included age, duration be compared with IgA-N. Liver biopsy specimens from a of the disease prior to biopsy, gender, recurrent macroscopic patient with cirrhosis due to alcohol abuse were used as positive haematuria, nephrotic syndrome, persistent or intermittent controls, while negative controls were established by proteinuria and/or microscopic haematuria, and hyperten-substituting mAbs with an irrelevant mouse IgG [17] . sion, characterized by the requirement of regular medication or a blood pressure >140/90 mmHg on at least three occa-
Circulating immune complex (CIC) detection and
sions. The laboratory assessment at the time of biopsy included routine urinalysis, 24 h urine protein excretion, and measurement of soluble C5b-9 (sC5b-9) by ELISA 24 h creatinine clearance. Serum immunoglobulin levels (IgG, IgA, and IgM ) and serum complement levels (C3 and C4) Commercially available ELISA kits were used for circulating were also measured. Blood samples were obtained on the immune complex (CIC ) detection (FRELISA C3d-CIC day of biopsy and stored at −80°C until analysis. All patients ELISA kit; QUIDEL, San Diego, CA) and for the measuregave informed consent prior to entry into the study. ment of sC5b-9 (SC5b-9 Enzyme Immunoassay kit; Findings by light microscopy were evaluated semi-QUIDEL). For CIC detection, serum samples were added quantitatively using a grading system previously descrived to wells coated with a mAb against C3d, and a peroxidaseby Andreoli and Bergstein [14] . All biopsy specimens were conjugated mAb against human IgG or human IgA was used scored for activity (percentage of glomeruli demonstrating as the secondary antibody. For quantitation of sC5b-9, crescent formation, degree of mesangial proliferation and plasma samples were added to wells coated with a mAb interstitial infiltrate; maximum score=9) and chronicity (per-against a neo-epitope of human sC5b-9 and peroxidasecentage of glomeruli demonstrating fibrous crescents, seg-conjugated goat polyclonal antibodies to C6 and C7 were mental sclerosis, global sclerosis, and degree of tubular added. Amounts of IgG CICs were expressed as microgram atrophy and interstitial fibrosis; maximum score=12). equivalents of human IgG, IgA CICs were expressed as OD Specimens for direct immunofluorescent microscopy were units, and sC5b-9 was expressed in ng/ml. Thirty-five healthy prepared by standard methods [5] . For the detection of IgG, volunteers were utilized as controls. IgA, IgM, C1q, C4c, C3c, properdin, and fibrinogen, sections of frozen kidney specimens were stained with fluorescein Statistical analysis isothiocyanate-labelled rabbit or goat antibodies against each of these proteins (DAKO Japan Co. Ltd, Tokyo, Japan and Significant differences between groups were determined by Nordic Immunological Laboratories, Tilburg, Netherlands), the Mann-Whitney U-test and P values <0.05 were considand examined with a fluorescent microscope and evaluated. ered significant. Data are presented as mean values±SD.
Immunohistochemical staining for components of the

Results
lectin pathway
The following monoclonal mouse anti-human antibodies Glomerular deposition of components of the lectin (mAb) were used in this study: mAbs against MBL (3E7) pathway and MASP-1 (4C2) were obtained as previously described
In normal kidney tissues, neither MBL nor MASP-1 [15, 16 ] . A mAb against C3b/C3c (C-5G), which reacts with C3b and C3c but not with native C3 nor with C3dg, was was detected ( Figure 1a,b) . Eleven of 45 cases (24.4%) Table 2 ) (×360): these show co-distribution predominantly in the mesangium.
with IgA-N demonstrated staining of glomeruli with a similar distribution pattern in the same glomerulus (Figure 1e,f ) . In the 34 cases without MBL, with mAbs against MBL and MASP-1 (Figure 1c,d) . All of the 11 cases with MBL/MASP-1 were accompan-although most of the cases (31 and 34 of 34, respectively) also demonstrated glomerular deposition of ied by glomerular deposition of C3b/C3c and C5b-9 were young at the time of renal biopsy and their disease was a short duration. No other features were Individual IF and histological parameters of IgA-N deduced in connection with MBL/MASP-1 deposition with glomerular MBL/MASP-1 deposition, as deter-from these data (gender, clinical onset, urinary protein, mined by the examination of renal biopsies, are sum-haematuria, creatinine clearance, or serum levels of marized in Table 2 . IgA was clearly the predominant IgA, C3, or C4). immunoglobulin class deposited in the mesangial area When the patients with IgA-N were divided into of the glomeruli. In all 11 cases, C3c was distributed two groups according to the presence or absence of in a pattern similar to that of IgA. Similar but less glomerular MBL deposition, the plasma levels of intense staining was also observed for IgG in 4 of 11 IgG-CICs, IgA-CICs, and sC5b-9 were not significcases (36.4%), for IgM in 3 of 11 cases (27.3%), for antly different between the groups (6.25±2.44 mgEq/ fibrinogen in 2 of 11 cases (18.2%), for C1q in 1 of 11 ml vs 5.58±2.32 mgEq/ml, 0.37±0.16 U vs 0.35± cases (9.1%), for C4c in 4 of 11 cases (36.4%), and for 0.12 U, and 329.0±169.3 ng/ml vs 308.6±104.1 ng/ml, properdin in 6 of 11 cases (54.5%). Light microscopic respectively) (Figure 2) . studies revealed that the activity index was 3.4±2.0 (range, 2-8) and that the chronicity index was 1.5±1.9 (range, 0-6). These results demonstrate that glomerDiscussion ular deposition of MBL/MASP-1 is associated with histologic alterations at an early stage of the disease and not with the advanced stage.
The pathogenesis of IgA-N has not been determined despite a great deal of research. A deeper understanding of the mechanism of complement activation in is apparent that the complement system participates in the development of the disease [7] . Some cases with activation in situ ( Table 1) . 
Abbreviations are: Fib, fibrinogen; Pr, properdin; Al, activity index; Cl, chronicity index. Although it has been accepted widely that complement complexes are not always necessary for complement activation in IgA-N because mesangial C3 deposits were activation in IgA-N occurs mainly via the alternative pathway [1] , several reports [7] [8] [9] suggest that the clas-present even in the absence of IgG or IgM deposits (Table 2 ). In the lectin pathway, MBL/MASPs complex sical pathway may also be involved. Miyazaki et al. [8] found glomerular deposition of C4 in 30% of patients activates the complement cascade by consuming C4 and C2 [11] , and in addition, cleaves C3 directly, which with IgA-N and glomerular deposition of C4-binding protein (C4-bp), which was the sensitive indicator for subsequently activates the alternative pathway [18] .
Consequently, the components of both the classical paththe classical pathway activation, in 60% of patients with IgA-N. It, however, seems that IgG-IgA or IgM-IgA way and the alternative pathway are involved. It should be noted that the cases with glomerular and serves as a trigger for the activation of the amplification cycle via the alternative pathway and that this MBL/MASP-1 deposition were young and the duration of the disease prior to biopsy was short compared with initiation is associated with repeated antigen exposures such as infection. This suggests a novel mechanism of that in cases without MBL/MASP-1 deposition ( Table 3 ). These findings suggest that the lectin path-complement activation in IgA-N and may provide an insight into the aetiology of this disease. way participates in the development of the disease at an early stage in consideration of the result that none reflect decreased galactosylation in N-linked glycans 
